ArticleInternational journal of chronic obstructive pulmonary disease2025
Sub-Optimal Chronic Obstructive Pulmonary Disease (COPD) Management in India: Findings from a Community-Based Study.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background and Objective: Despite the second most common cause of disease burden, there are few studies reporting the prevalence, awareness, and treatment rates of COPD in India. Methods: A community-based cross-sectional study was conducted among people aged ≥40 years residing in rural and urban areas of Sonipat district in North India using a multistage random sampling technique. COPD was defined as self-reported physician diagnosed COPD, emphysema, chronic bronchitis or being on treatment for COPD. Additional cases were detected using a validated sequential screening strategy, ie, administering the Lung Function Questionnaire (LFQ) followed by the pocket spirometry and confirmation by post-bronchodilation spirometry. Awareness was defined as self-reported diagnosed cases of COPD or self-reported treatment. Treatment was defined as self-reported intake of oral or inhalational corticosteroids and/or bronchodilators. Trained Community Health Workers interviewed the study participants using a paper-based validated questionnaire, screened for COPD with the LFQ and conducted the pocket spirometry. Confirmation of COPD using post-bronchodilation gold standard spirometry was conducted by trained physician researchers. Age-standardized estimates were calculated for the prevalence, awareness, and treatment of COPD. Results: The overall age-standardised prevalence of COPD in our study was 8.6% (95% CI: 7.5-9.8) with higher prevalence in men and rural population. The overall awareness of COPD was 75.1% (95% CI: 68.5-80.7) with lower awareness among people who ever-smoked [33.9% (32.0-35.8)], currently smoked [29.6% (27.8-31.5)] and among those with post-bronchodilator confirmed diagnosis of mild COPD (4.8%). Less than half (45.7%) of participants with COPD reported taking bronchodilators and/or corticosteroids. Conclusion: The awareness-treatment gap in COPD was high in the study population. There is a need to strengthen the public health system along with systematic training of health care providers to provide appropriate treatment to people with COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.